SPACE SAVING CHART - The space saving chart SSC-370 achieves the - NIDEK CO.,LTD.

Duns Number:690635461

Device Description: The space saving chart SSC-370 achieves the refraction distance of 5 m within an installat The space saving chart SSC-370 achieves the refraction distance of 5 m within an installation distance*1 of 1.1 m. The SSC-370 is a chart presenting device. The built-in optical system presents charts toward the back of the chart window. The VA (visual acuity) charts are composed of the four types of letters, Tumbling E, number, and children.

Want to know more about this Product? Request more information now!


More Product Details

Catalog Number

-

Brand Name

SPACE SAVING CHART

Version/Model Number

SSC-370

Device Commercial Distribution Status

In Commercial Distribution

Commercial Distribution End Date

-

Issuing Agency

In GS1

Product Characteristics

MRI safety Status

Labeling does not contain MRI Safety Information

Device required to be labeled as containing natural rubber latex or dry natural rubber (21 CFR 801.437)

-

Device labeled as "Not made with natural rubber latex"

-

For Single-Use

-

Prescription Use (Rx)

Yes

Over the Counter (OTC)

-

Kit

-

Combination Product

-

Human Cell, Tissue or Cellular or Tissue-Based Product (HCT/P)

-

FDA Premarket Submission

-

Product Code Details

Product Code

HOX

Product Code Name

Chart, Visual Acuity

Device Record Status

Public Device Record Key

f3a25178-720c-4c4a-a222-407c9156f386

Public Version Date

July 22, 2019

Public Version Number

2

DI Record Publish Date

April 20, 2018

Additional Identifiers

Package DI Number

None

Quantity per Package

-

Contains DI Package

-

Package Discontinue Date

-

Package Status

-

Package Type

-

"NIDEK CO.,LTD." Characteristics
Device Class Device Class Description No of Devices
1 A medical device with low to moderate risk that requires general controls 39
2 A medical device with a moderate to high risk that requires special controls. 73
3 A medical device with high risk that requires premarket approval 5